Guest guest Posted September 18, 2005 Report Share Posted September 18, 2005 designated medication? Recently read a Financial News article on Cypress Bio Science Inc revisited same this pm. One of the products late in phase III Clinical Trial is Milnacipran : ... " first of a new class of agents known as norepinephrine serotonin reuptake inhibitors, or NSRIs, which increase the level of norepinephrine more than they do serotonin... .....Milnacipran has not been approved in the United States for any indication, and we are the first company conducting clinical trials of milnacipran in the United States for FMS. " (I work in a firm assciated with medical industry when we get a product intoPhase III Trials we are nearly home,it is certainly late in the game as to convincing the FDA to approve product for market. That said, the latter phase of the Phase III Milnacipran Clinicals began in Oct 2004) Gimpi Discussing Milnacipran : http://tinyurl.com/dtgbh Phase II Clinical Trial results: http://tinyurl.com/bhwn3 Phase III Clinicals : http://tinyurl.com/chqvx Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.